Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Completed 70 enrolled Tanta University

RandomizedParallel-groupOpen-labelTreatment

Summary

This study aimed to compare the efficacy, safety, and tolerability of electroconvulsive therapy (ECT) versus intravenous (IV) ketamine in adults with treatment-resistant major depressive disorder (TRD).

Timeline

Start: 2025-07-01
Primary completion: 2026-02-01
Completion: 2026-02-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Ketamine	Small molecule	0.5 mg/kg	Intravenous

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Summary

Timeline

Drugs

Indications